Indicaton
Epilepsy
Milestone: H2 2023
ADX71149 for the treatment of epilepsy.
ADX71149 is a selective metabotropic glutamate sub-type 2 (mGlu2) receptor positive allosteric modulator (PAM).
Epilepsy
Milestone: H2 2023
ADX71149 for the treatment of epilepsy.
ADX71149 is a selective metabotropic glutamate sub-type 2 (mGlu2) receptor positive allosteric modulator (PAM).